Market News & Trends
G1 Therapeutics Announces Clinical Trial Collaboration With Genentech
G1 Therapeutics recently announced a clinical trial collaboration with Genentech, a member of the Roche Group. A Phase II clinical trial is expected to begin…
Amgen & Allergan Submit Biosimilar Marketing Authorization Application
Amgen and Allergan plc. recently announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ABP 215, a biosimilar…
Impel NeuroPharma Announces $36-Million Funding to Advance Novel Delivery Platform
Impel NeuroPharma, Inc. recently announced that it has closed a Series C funding round in an amount up to $36 million to advance its novel…
Catalent Becomes First CDMO to Join Pharmaceutical Supply Chain Initiative
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, recently announced that it had…
VBL Therapeutics Announces Overall Survival Data for VB-111 Monotherapy in Phase 2 Study
VBL Therapeutics recently announced top-line results from its exploratory Phase II study of VB-111 (ofranergene obadenovec) in patients with advanced, differentiated thyroid cancer. As previously…
OncoMed Presents Initial First-in-Human Data
OncoMed Pharmaceuticals Inc. presented initial first-in-human data from its ongoing Phase I clinical trials of anti-DLL4/VEGF bispecific (OMP-305B83) and anti-RSPO3 (OMP-131R10) antibodies in two posters…
Novan Announces Statistically Significant Phase II Clinical Trial Results
Novan, Inc. recently announced top-line results from the company’s Phase II clinical trial with SB206 for the treatment of genital warts caused by human papillomavirus,…
Cellular Biomedicine Group Approved to Commence Phase I Trial
Cellular Biomedicine Group Approved to Commence Phase I Trial Cellular Biomedicine Group Inc. (CBMG) recently announced the approval and commencement of patient enrollment in China…
Catalent Acquires Company to Expand Softgel Development & Manufacturing
Catalent, Inc. recently announced it has agreed to acquire Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency, and conventional pharmaceutical…
Ablynx Achieves First Milestone From Novo Nordisk
Ablynx recently announced it has achieved an initial discovery milestone with a multi-specific Nanobody construct as part of its collaboration with Novo Nordisk, triggering a…
Stealth Biotherapeutics Announces Positive Phase II Clinical Trial Findings
Stealth BioTherapeutics recently presented results from the EVOLVE trial, which demonstrated that a single dose of elamipretide prior to renal artery angioplasty and stenting procedures…
TKL Research Agrees to Sell Clinical Trials Division
TKL Research, a dermatology specialty clinical research organization (CRO), recently announced it has signed an agreement to sell its Clinical Trials Division (CTD) to QuintilesIMS. Upon…
IP Assets of Biopharmaceuticals Delivery Specialists Brought to Market by Metis Partners
The IP assets of a recognized leader in the bioformulation and drug delivery industry, XstalBio Limited, which is behind CentuRecon – a patent-backed reconstitution technology…
West Announces Expanded Contract Manufacturing Capabilities in Ireland
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot…
Honeywell Launces New Research Chemicals Business to Optimize Product Partnerships With Researchers
Honeywell recently announced the launch of a new business, Honeywell Research Chemicals, that will now include several brands and solvent and inorganic chemical products that…
Mustang Bio Presents Clinical & Preclinical Data on MB-101 for Treatment of Glioblastoma
Mustang Bio, Inc., a Fortress Biotech company, recently announced that Phase I clinical data and preclinical data on its MB-101 [IL13Rα2-specific Chimeric Antigen Receptor–engineered CAR…
Biogen Renews License With Absorption Systems
Absorption Systems, a world leader in novel test systems for drug transporters, recently announced the renewal of a technology licensing deal with Biogen. After years…
Vetter: Choosing the Right Diluent to Help Maximize Success
Choose the Right Diluent to Help Maximize Success The biologics market continues to rise, expecting to reach $250 billion by 2024. Due to the unstable nature…
Healthcare Companies Must Embrace New Funding Sources as Venture Investment Continues to Decline
Although the life sciences industry remains an attractive investment area, the healthcare sector has seen a decline in venture investments, particularly for early stage investments,…
PCI Clinical Services Announces Significant Expansion
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is extending its current Cryogenic storage capabilities to its Rockford, IL, operations, complementing the specialized capability…
